Management of adult generalized pustular psoriasis using biologics: A systematic review - 15/07/23
Doi : 10.1016/j.jaad.2023.04.031
Abrahim Abduelmula, BScN a, Brian D. Rankin, MD, PhD b, Siddhartha Sood, HBSc c, Jorge R. Georgakopoulos, MD d, Asfandyar Mufti, MD d, Ronald Vender, MD e, f, Jensen Yeung, MD d, g, h, i, Vimal H. Prajapati, MD b, j, k, l, m, n, ⁎ 
a Faculty of Medicine, University of Western Ontario, London, Ontario, Canada
b Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada
c Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
d Division of Dermatology, Department of Medicine, University of Toronto, Ontario, Canada
e Department of Dermatology, McMaster University, Hamilton, Ontario, Canada
f Dermatrials Research Inc & Venderm Innovations in Psoriasis, Hamilton, Ontario, Canada
g Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada
h Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
i Probity Medical Research, Waterloo, Ontario, Canada
j Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
k Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
l Dermatology Research Institute, Calgary, Alberta, Canada
m Skin Health & Wellness Centre, Calgary, Alberta, Canada
n Probity Medical Research, Calgary, Alberta, Canada
∗Correspondence to: Vimal H. Prajapati, MD, Dermatology Research Institute, Suite 310, 8500 Blackfoot Trail S.E. Meadows Mile Professional Building, Calgary, Alberta, Canada T2J 7E1Dermatology Research InstituteSuite 310, 8500 Blackfoot Trail S.E. Meadows Mile Professional BuildingCalgaryT2J 7E1Canada
Key words : adult, biologics, evidence-based, generalized pustular psoriasis, IL-36, systematic review, therapeutics
| Funding sources: None. |
|
| IRB approval status: Not applicable. |
© 2023
Publié par Elsevier Masson SAS.
Vol 89 - N° 2
P. 417-419 - août 2023 Retour au numéro
Article précédent
- Efficacy, safety, and treatment patterns of ruxolitinib 1.5% cream in adult atopic dermatitis: A single center retrospective study
- Nicole S. Stefanko, Victor L. Quan, Raj Chovatiya
- Retrospective analysis of management concordance between primary care providers and teledermatologists after electronic consultation
- Colby A. Foster, Ahab Chopra, Milad Eshaq
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?